Zobrazeno 1 - 5
of 5
pro vyhledávání: '"H. Barry Baker"'
Autor:
Quyen Luu, Lucinda J. Van Anglen, Alfred E. Bacon, Richard C. Prokesch, Claudia P. Schroeder, Carson T Lo, Ramesh V Nathan, Richard L Hengel, Kimberly A Couch, H. Barry Baker
Publikováno v:
Open Forum Infectious Diseases
Background The Hospital Readmissions Reduction Program was established under the Affordable Care Act in 2012 to reduce payments to hospitals (hosp) with excess readmissions. Standardized readmission measures include all-cause unplanned readmissions w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ae01722dbdf8d2261fd534c3fa1e4a
http://europepmc.org/articles/PMC6809033
http://europepmc.org/articles/PMC6809033
Autor:
Claudia P. Schroeder, H. Barry Baker, Lucinda J. Van Anglen, Richard C. Prokesch, Quyen Luu, Robin H. Dretler, Andrew H. Krinsky
Publikováno v:
Open Forum Infectious Diseases. 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6220a5d5342e0240c13eb152703e3048
https://doi.org/10.1093/ofid/ofw172.162
https://doi.org/10.1093/ofid/ofw172.162
Autor:
Quyen Luu, Lucinda J. Van Anglen, Alfred E. Bacon, H. Barry Baker, Ramesh V Nathan, Kimberly A Couch, Richard M. Mandel, Andrew H. Krinsky, Claudia P. Schroeder
Publikováno v:
Open Forum Infectious Diseases
Background The aged population (≥75 years) have multiple comorbidities and are at increased risk of adverse events associated with intravenous antimicrobial therapy. Hospitalization (hosp) occurs frequently. This group presents challenges for site
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8baf31cf4333e5fcca5539f7d35f0c11
http://europepmc.org/articles/PMC5631271
http://europepmc.org/articles/PMC5631271
Autor:
Lucinda J. Van Anglen, H. Barry Baker, Robin H. Dretler, Barry Statner, Quyen Luu, Thomas C. Hardin, Brian S Metzger, Claudia P. Schroeder
Publikováno v:
Open Forum Infectious Diseases
Background Medicare beneficiaries and patients (patients) ≥65 years comprise the highest risk for utilization of healthcare resources including emergency department (ED) visits and hospitalizations (hosp). Dalbavancin (DAL) is a long-acting lipogly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae2902641b47e14c78af301ae45bffb9
https://doi.org/10.1093/ofid/ofy210.2033
https://doi.org/10.1093/ofid/ofy210.2033
Autor:
H. Barry Baker, Lucinda J. Van Anglen, Richard M. Mandel, Richard C. Prokesch, Robin H. Dretler, Claudia P. Schroeder, Fernando S. Alvarado, Brian D. Metzger
Publikováno v:
Open Forum Infectious Diseases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2efc588f13ffcd20525a60f528ecd38b
http://europepmc.org/articles/PMC5781390
http://europepmc.org/articles/PMC5781390